Geopolitics Alpha

Aclaris Therapeutics, Summit Therapeutics And Other Big Stocks Moving Lower In Monday’s Pre-Market Sessio

Published . Updated .

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.

GEOPOLITICS ALPHAAclaris Therapeutics, SummitTherapeutics And Other Big StocksMoving Lower In Monday’s…ACRSSMMTGEOPOLITICS ALPHA

This report is about the broad US market.

Directly affected

  • ACRS Aclaris Therapeutics

    Named in this report.

  • SMMT Summit Therapeutics

    Named in this report.

Indirectly affected

  • DIA SPDR Dow Jones Industrial Average ETF

    SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story.

  • QQQ Invesco QQQ

    Invesco QQQ: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story.

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that Aclaris Therapeutics belongs to, so it often moves with news about it.

  • LLY Eli Lilly and

    Eli Lilly and is a peer of Aclaris Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • JNJ Johnson & Johnson

    Johnson & Johnson is a peer of Aclaris Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • ABBV AbbVie

    AbbVie is a peer of Aclaris Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • MRK Merck

    Merck is a peer of Aclaris Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • ABT Abbott Laboratories

    Abbott Laboratories is a peer of Aclaris Therapeutics in pharmaceutical preparations; rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
ACRS+8.70%+11.00%baseafter closeafter closeafter closeafter close
SMMT+26.12%+17.57%baseafter closeafter closeafter closeafter close
DIA+0.04%+0.26%baseafter closeafter closeafter closeafter close
QQQ-0.18%+1.53%baseafter closeafter closeafter closeafter close
XLV-0.28%+0.04%baseafter closeafter closeafter closeafter close
LLY-2.25%-0.49%baseafter closeafter closeafter closeafter close
JNJ-1.35%-1.97%baseafter closeafter closeafter closeafter close
ABBV-0.57%-0.04%baseafter closeafter closeafter closeafter close
MRK+0.65%-0.38%baseafter closeafter closeafter closeafter close
ABT+1.85%+0.80%baseafter closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Aclaris Therapeutics, Summit Therapeutics And Other Big Stocks Moving Lower In Monday’s Pre-Market Sessio Benzinga

Source: Benzinga

This story

CompanyWhenMoveStatus
ABBVthree days earlier-0.04%final price
ABBVfive days earlier-0.57%final price
ABTthree days earlier+0.80%final price
ABTfive days earlier+1.85%final price
ACRSthree days earlier+11.00%final price
ACRSfive days earlier+8.70%final price
DIAthree days earlier+0.26%final price
DIAfive days earlier+0.04%final price
JNJthree days earlier-1.97%final price
JNJfive days earlier-1.35%final price
LLYthree days earlier-0.49%final price
LLYfive days earlier-2.25%final price
MRKthree days earlier-0.38%final price
MRKfive days earlier+0.65%final price
QQQthree days earlier+1.53%final price
QQQfive days earlier-0.18%final price
SMMTthree days earlier+17.57%final price
SMMTfive days earlier+26.12%final price
XLVthree days earlier+0.04%final price
XLVfive days earlier-0.28%final price

Congressional trades in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

This story

12 out of 100

“Aclaris Therapeutics, Summit Therapeutics And Other Big Stocks Moving Lower In Monday’s Pre-Market Sessio” scores 12 out of 100. The score uses 1 sources.